Scope and Purpose
State the policy’s applicability (clinical care, research, public health), objectives, and the populations and test types covered to avoid ambiguity about when the policy applies and who must follow it.
A written policy reduces legal and clinical risk by standardizing consent, specimen handling, result reporting, and recordkeeping across staff and locations. It helps ensure HIPAA compliance and reproducible procedures necessary for quality control, audits, and regulatory review.
Organizations use a Healthcare Participant Testing Policy to coordinate testing activities and document participant consent and results across clinical and research settings.
The policy supports consistent implementation by staff, reduces rework, and clarifies responsibilities across clinical, laboratory, and administrative teams.
Manages participant enrollment, documents informed consent, schedules specimen collection, and maintains study records. Coordinates with IRB and lab services to ensure tests follow the study protocol and regulatory obligations.
Oversees policy review, trains staff on HIPAA safeguards and e-signature procedures, and conducts periodic audits. Acts as primary contact for regulators and ensures retention and breach-prevention measures are implemented.
State the policy’s applicability (clinical care, research, public health), objectives, and the populations and test types covered to avoid ambiguity about when the policy applies and who must follow it.
Define key terms such as participant, specimen, chain of custody, informed consent, result categories, and adverse event to ensure consistent interpretation by clinical and administrative staff.
Describe informed consent requirements, consumer disclosure for electronic consent per ESIGN (when consumer-facing), identity verification steps, and procedures for withdrawing consent.
Provide detailed collection instructions, labeling, transport conditions, storage temperatures, and chain-of-custody documentation to preserve specimen integrity and result validity.
Specify reporting timelines, positive/negative result workflows, required clinician sign-off, public health notifications, and participant communication protocols.
Outline PHI protections, audit logging, encryption requirements, retention periods aligned with HIPAA and IRS/other regulators, and procedures for secure deletion or archival.
| Field | Configuration |
|---|---|
| Identity Verification | Enable ID check or SMS code |
| Consent Capture | Require signed date and checkbox |
| Result Routing | Auto-route to clinician and record owner |
| Retention Policy | Set automatic archival per retention |
Use a platform that supports HIPAA safeguards, audit trails, standard document formats, and common integrations for clinical systems.
Confirm the vendor can provide a BAA, produce tamper-evident signed documents, and export audit logs for compliance review.
MM/DD/YYYY; defines coverage period
Per protocol or within X days
Report positives per health department rules
Retention begins on creation date
Policy review at least annually
Participant registration and ID check completed.
Signed consent recorded prior to specimen collection.
Specimen collected, labeled, and processed per protocol.
Results reported and record archived under retention rules.
| signNow | DocuSign | Adobe Sign | PandaDoc | HelloSign | |
|---|---|---|---|---|---|
| Starting Price | $8/user/mo | $15/user/mo | $14/user/mo | $19/user/mo | $15/user/mo |
| Free Trial | 7-day free trial | Verify with vendor | Verify with vendor | Verify with vendor | Verify with vendor |
| Bulk Send | Yes | Yes | Yes | Yes | No |
| Audit Trail | Yes | Yes | Yes | Yes | Yes |
| HIPAA Compliant | Yes | Yes | Yes | No | No |
| Envelope Cap | No cap | 100 envelopes/user/year | Varies by plan | Varies by plan | Varies by plan |
An urban hospital standardized consent and specimen handling across three clinics to reduce errors by audit findings
A multi-site clinical trial harmonized participant testing procedures and e-consent language across sites